
Niva Bupa Health Insurance Downgraded to Strong Sell Amid Valuation and Financial Concerns
2026-02-02 08:56:39Niva Bupa Health Insurance Company Ltd has been downgraded from a Sell to a Strong Sell rating as of 30 January 2026, reflecting deteriorating valuation metrics, flat financial trends, and weak technical signals. The company’s Mojo Score has dropped to 26.0, underscoring heightened risk perceptions amid challenging market conditions and disappointing quarterly results.
Read full news article
Niva Bupa Health Insurance Valuation Shifts Signal Elevated Risk Amid Peer Comparisons
2026-02-01 08:07:21Niva Bupa Health Insurance Company Ltd has experienced a marked deterioration in its valuation metrics, shifting from a previously expensive rating to a risky classification. This change, coupled with weak profitability indicators and a challenging peer comparison, raises significant concerns for investors assessing the stock’s price attractiveness amid a volatile insurance sector.
Read full news article
Niva Bupa Health Insurance Company Ltd is Rated Strong Sell
2026-01-31 10:10:48Niva Bupa Health Insurance Company Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 30 January 2026. However, all fundamentals, returns, and financial metrics discussed below reflect the stock’s current position as of 31 January 2026, providing investors with the most up-to-date analysis.
Read full news articleAre Niva Bupa Health Insurance Company Ltd latest results good or bad?
2026-01-30 19:29:04Niva Bupa Health Insurance Company Ltd has reported its latest financial results for Q2 FY26, revealing a complex operational landscape. The company recorded net sales of ₹1,422.05 crores, reflecting a year-on-year growth of 17.21% and a quarter-on-quarter increase of 16.56%. However, despite this revenue growth, Niva Bupa continues to face significant challenges in profitability, posting a net loss of ₹35.27 crores for the quarter, which marks its second consecutive quarterly loss in the current fiscal year. The operating margin for Q2 FY26 was reported at -3.74%, an improvement from -7.62% in Q1 FY26, indicating some progress in cost management initiatives. However, this margin remains substantially lower than the operating margin of 16.41% achieved in Q4 FY25, highlighting ongoing volatility in operational performance. The company's return on equity (ROE) stands at 5.00%, which is below the industry ave...
Read full news article
Niva Bupa Health Insurance Q2 FY26: Losses Deepen as Growth Momentum Falters
2026-01-29 21:04:17Niva Bupa Health Insurance Company Limited reported a net loss of ₹35.27 crores in Q2 FY26, marking a significant deterioration from the ₹13.02 crore profit posted in the same quarter last year. The quarter-on-quarter performance showed marginal improvement with losses narrowing by 61.43% from Q1 FY26's ₹91.44 crore loss, yet the company remains mired in operational challenges despite posting decent top-line growth. The stock, currently trading at ₹78.00 with a market capitalisation of ₹14,297 crores, has underperformed the broader insurance sector by 24.26 percentage points over the past year.
Read full news articleWhen is the next results date for Niva Bupa Health Insurance Company Ltd?
2026-01-21 23:16:45The next results date for Niva Bupa Health Insurance Company Ltd is scheduled for January 29, 2026....
Read full news article
Niva Bupa Health Insurance Company Ltd is Rated Sell
2026-01-20 10:10:24Niva Bupa Health Insurance Company Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Niva Bupa Health Insurance Company Ltd is Rated Sell
2026-01-09 10:10:25Niva Bupa Health Insurance Company Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 31 July 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics presented here are based on the company’s current position as of 09 January 2026, providing investors with the latest insights into its performance and valuation.
Read full news article
Niva Bupa Health Insurance Company Ltd is Rated Sell
2025-12-29 10:10:04Niva Bupa Health Insurance Company Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 31 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 December 2025, providing investors with an up-to-date view of its performance and outlook.
Read full news articleAnnouncement under Regulation 30 (LODR)-Earnings Call Transcript
03-Feb-2026 | Source : BSETranscript of the Earnings call held on January 29 2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
02-Feb-2026 | Source : BSECopy of Newspaper publication of Unaudited Financial Results for the quarter and nine months ended December 31 2025.
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
29-Jan-2026 | Source : BSESubmission of audio recording of the Earnings call conducted on January 29 2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






